Prof. Jianqun Ma 马建群
Chief Physician, Professor
Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and surgical treatment of chest tumors, including lung cancer, esophageal cancer, and mediastinal tumors. Expertise in thoracoscopic lobectomy, totally thoracoscopic esophagectomy, and managing postoperative complications.
Dr. Ma is Chief Physician and Professor at Harbin Medical University Cancer Hospital. Holding an MD and postdoctoral experience from UPMC and Cedars Sinai, Dr. Ma has nearly 30 years of clinical experience. Research focuses on non-small cell lung cancer and minimally invasive techniques. Dr. Ma has led nine research projects and published over 20 papers.
Professional roles
- Member, International Association for the Study of Lung Cancer
- Editorial Board Member, Chinese Journal of Clinical Rehabilitation
- Member, Heilongjiang Provincial Thoracic and Cardiovascular Surgery Society
- Member, Heilongjiang Provincial Esophageal Cancer Professional Committee
Name order: in Chinese the family name comes first (Ma Jianqun). Papers usually list the name as Jianqun Ma or Ma J.
Selected publications
61 papers on PubMed matched by name and affiliation; 22 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMC Med, 2025 (senior author): Preoperative conversion therapy of camrelizumab combined with paclitaxel and nedaplatin for unresectable advanced esophageal squamous cell carcinoma: a phase 2 study. PubMed 41456046
- J Thorac Dis, 2025 (senior author): Factors linked to lung cancer in MIMIC-IV database. PubMed 40529779
- Int Immunopharmacol, 2024 (first author): LncRNA HAR1A inhibits non-small cell lung cancer growth by downregulating c-MYC transcripts and facilitating its proteasomal degradation. PubMed 39340992
- Cancer Cell Int, 2024 (senior author): A comprehensive prognostic and immunological implications of PFKP in pan-cancer. PubMed 39252014
- Cell Death Discov, 2024 (senior author): METTL3-mediated deficiency of lncRNA HAR1A drives non-small cell lung cancer growth and metastasis by promoting ANXA2 stabilization. PubMed 38688909
- J Thorac Dis, 2024 (senior author): Robot-assisted minimally invasive esophagectomy versus minimally invasive esophagectomy for thoracic lymph node dissection in patients with squamous cell carcinoma: a retrospective comparative cohort study. PubMed 38617764
- EBioMedicine, 2024 (senior author): Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma. PubMed 38101299
- Hum Cell, 2024 (senior author): Nucleoporin 93, a new substrate of the E3 ubiquitin protein ligase HECTD1, promotes esophageal squamous cell carcinoma progression. PubMed 37993750
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion